Investigations of the last decade have revealed that cell membranes, although only 100 A thick, are the site of many complex enzyme reactions, as illustrated, for example, by the well-studied mitochondrial membranes (see refs. 1-3). The molecular organization of membranes is far from being established; they are apparently a mosaic of functional units formed by lipoprotein complexes.4 The excitable membranes, i.e. the plasma membranes surrounding nerve and muscle fibers, have the special ability to change, rapidly and reversibly, their permeability to ions. The resulting ion movements are the carriers of bioelectric currents propagating nerve impulses along nerve and muscle fibers. The idea of a purely physical process assumed in the ionic theory is difficult to reconcile with the large amounts of heat produced and absorbed during electrical activity. The most likely explanation of the results of the heat measurements is the assumption that chemical reactions underly the permeability cycle in excitable membranes. 5 In view of the central role of enzymes and proteins in cell mechanisms, it appears reasonable to assume that they play an essential role in the elementary process of excitable membranes, i.e. in bioelectricity.
In the last 30 years evidence has accumulated for the assumption that acetylcholine (ACh) acts as a trigger, controlling ion movements across excitable membranes. The principal bases for this view may be briefly summarized: (1) ACh and the enzymes which hydrolyze and form it (ACh-esterase and choline O-acetyltransferase (choline acetylase)) have been shown to be present in all types of conducting fibers of nerve and muscle throughout the animal kingdom: In motor and sensory, "cholinergic" and "adrenergic," peripheral and central fibers, in invertebrates and vertebrates, etc. (2) ACh-esterase, an enzyme relatively specific for ACh and distinctly different from other esterases, is localized in the excitable membranes of axons and muscle fibers as well as in those of junctions, i.e. in the membranes of nerve terminals and in the postsynaptic membranes. (3) ACh-esterase hydrolyzes ACh in a few microseconds, a prerequisite for attributing to the ester the proposed role as a trigger in the generation of bioelectric currents. (4) An extraordinarily high concentration of the enzyme has been found in the electric organs of electric fish. These organs, the most powerful bioelectric generators developed by nature, are highly specialized in their function. Although formed by 3 per cent protein and 92 per cent water, 1 kg (fresh weight) of electric tissue of Torpedo and Electrophorus hydrolyzes 3-4 kg of ACh per hour. For the last 30 years this tissue has been essential for the analysis of the proteins specifically associated with bioelectrogenesis. (5) Specific and potent inhibitors of ACh-esterase have been shown to block electrical activity in a great variety of nerve fibers, e.g. reversibly with physostigmine and irreversibly with diisopropylphosphofluoridate (DFP). Thus, electrical activity requires the activity of the enzyme present in the excitable membrane, which supports the assumption of its essential role in the permeability changes. (6) In axons exposed to organophosphates under conditions leading to an irreversible block of electrical activity, a powerful, specific reactivator of the phosphorylated enzyme, pyridine-2-aldoxime methiodide, may, under appropriate conditions, restore electrical activity. (7) The presence of a protein distinctly different from AChesterase, the ACh-receptor, has been demonstrated in many axonal membranes.
It has been shown that ACh and its congeners produce effects on the electrical parameters of axons similar to those previously observed on the junctional membranes, provided the structural barriers for lipid-insoluble quaternary nitrogen derivatives are inadequate to prevent the compounds from reaching the receptor or are reduced by chemical treatment. (8) Differences between the molecular groups of the active site of the ACh-receptor and those of the enzyme have been shown using the monocellular electroplax preparation of Electrophorus. (9) Lipid-soluble inhibitors of the ACh-receptor that are analogs of ACh, such as certain local anesthetics, block electrical activity in all excitable membranes, thus demonstrating the essential role of the ACh-receptor protein in bioelectrogenesis and supplementing the evidence for the essential role of the enzyme. The earlier experiments have been described in a monograph,6 and the more recent developments in reviews.7
The following description of the role of ACh seems to best fit the available information. ACh is released within the membrane by excitation; it acts as a signal recognized within the membrane by a specific ACh-receptor protein. The reaction induces a conformational change, thereby possibly releasing Ca++ ions bound to carboxyl groups of the protein. Ca++ ions have for a long time been known to be involved in the excitability of nerve and muscle fibers; the Ca++ ions released may induce further conformational changes of phospholipids and other polyelectrolytes. The end result of this sequence of chemical reactions is the change of ion permeability, permitting the movement of 20,000-40,000 or more ions across the membrane per molecule of ACh released. These reactions thus act as typical amplifiers of the signal given by ACh. By hydrolyzing ACh, ACh-esterase permits the return of the receptor to its original conformation; the barrier of the ion movements is thereby re-established. This paper describes some recent advances in the study of the two proteins that react directly with the specific signal, ACh-receptor and -esterase.
(1) ACh-Esterase.-For more than 20 years it was postulated, on the basis of indirect biochemical evidence, that ACh-esterase is localized in the excitable membrane. In the last five years many laboratories, using electron microscopy combined with histochemical techniques,8 have obtained direct evidence for such a localization. However, whereas it is easy to demonstrate the localization of the enzyme in the membranes of nonmyelinated fibers, in myelinated fibers the presence of the enzyme in the membrane appeared to be irregular or absent.9 Since, even in a slice of 500-1000 A thickness, structural barriers may impair the reactionl between the enzyme in the membrane and the added compounds, Brzin.0 applied Triton lOOX to slices of a myelinated single axon and found ACh-esterase in the plasma membrane located between the axoplasm and the myelin sheath.
Studies of ACh-esterase started in 1938 when this enzyme was first obtained in a highly active solution by extraction from electric organ." In the early 1940's a 500-fold purification of the enzyme was obtained but the amounts were small.'2 The preparation was useful for kinetic studies and for analyzing many reactions of ligands with the active site of the enzyme. Effects of organophosphates, and of other potent inhibitors of the enzyme widely used in neuropharmacology, were explained in terms of their reaction with molecular groups in the active site. 6' Developments in protein chemistry during the last decade, especially those permitting an analysis of molecular properties, made it desirable to obtain adequate amounts of enzyme protein. Using electric tissue, Leuzinger and Baker'4 recently worked out a large-scale purification which led to the crystallization of ACh-esterase."5 The crystals have the form of hexagonal prisms; the molecular weight of the enzyme is 260,000 (W. Leuzinger, lI. Goldberg, and E. Cauvin"5).
The protein has four subunits of about equal molecular weight and two different chains on the basis of the determinations of C-terminal groups.
(2) ACh-receptor.-The ACh-receptor has not been isolated as yet. However, an unusual preparation with many unique features was developed from isolated single cells of electric eels,'6 and was refined in the following years by Higman, Bartels, and Podleski.'7-29 The electrical parameters may be used as a most sensitive method for determining the reactions of ligands with the ACh-receptor and its interactions with other proteins.18 Information about the molecular groups in the active site of this protein is accumulating from studies using both receptor activators, i.e. compounds such as ACh and other congeners which apparently induce the conformational change and depolarize the membrane, and receptor inhibitors such as curare, local anesthetics, etc., which react specifically with the active site but do not depolarize and act as antimetabolites of ACh. '9 The affinities to the receptor have been compared with those to the ACh-esterase in solution. Some of the molecular groups of the active site are distinctly different from those of the enzyme.20 SH blocking and S-S reducing agents block the action of ACh on the receptor; washing out these agents does not restore the reaction, but chemical restoration of the SH and S-S groups does.21 This is evidence for the protein nature of the ACh-receptor. The same agents have no effect on ACh-esterase activity.22
Pertinent to the relationship of the receptor to its function has been a series of experiments performed on the electroplax with local anesthetics that are analogs of ACh. The action of ACh is usually limited to the membranes of the junction because the compound is unable to penetrate the structural barriers surrounding the excitable membranes of nerve and muscle fibers (see discussion below). In contrast, the local anesthetics penetrate the structural barriers and therefore act on the receptor in the membranes of conducting fibers as well as those of junctions. An analysis has been performed to test by which substitutions the ACh molecule is transformed into a "local anesthetic."23 The substitution of the methyl group on the carbon of the carbonyl group by a saturated ring decreases the potency of the compound as ali activator by more than 100-fold. Its action is limited to the junction. The substitution of the same methyl group by anl unsaturated ring leads to a compound (benzoylcholine) that has intermediary properties: accord-ing to conditions it may be either an activator or an inhibitor; moreover, it is capable of penetrating through structural barriers and of acting on the receptor in the conducting membrane. Addition of an amino group to the ring results in a classical "local anesthetic" that blocks electrical activity of the junction as well as of the axons. Small modifications of the structure, either of the ammonium or of the acyl group, may greatly increase the potency of the compound as a local anesthetic, as illustrated, for example, by procaine or tetracaine.
Recently, Changeux and Podleski applied to the electroplax membrane p-(trimethylamnonium)benzenediazonium fluoroborate (Tdf) prepared by Wofsy. 24 This ligand has been used for affinity labeling of enzymes and antibodies by Singer25 and his associates, and others. Tdf forms a covalent bond with the receptor at or near the active site. The block is irreversible. Another affinity labeling was achieved by Karlin in a two-step procedure. 4-(N-maleimido)phenyltrimethylammonium iodide blocks the receptor irreversibly in rather low concentrations but only after exposure of the electroplax to dithiothreitol (DTT), which reduces S-S bridges.26 Hexamethonium, a curare-like compound and an inhibitor of the receptor, after DTT treatment became a receptor activator and depolarized the membrane. The same ligand may thus have different, seemingly even opposite, biological actions, dependent on the condition of the macromolecule and other factors in the membrane.
Recent observations suggest certain similarities between the behavior of regulatory enzyme systems and the reactions of the excitable membranes to ligands acting on the receptor. The response of the electroplax to specific ligands is characterized (1) by the specific recognition of receptor activators which trigger the membrane depolarization, or of their antagonists, receptor inhibitors; and (2) by the deviation of the dose-response of several activators from the Langmuir isotherm. The dose-response curve of ACh has a sigmoid shape."7' 27 The Hill coefficient (n H) is about 2 as was first noticed by Karlin,28 who also calculated, on the basis of the data with SH blocking and S-S reducing compounds, that after treatment with these compounds the nH becomes 1. The changes from the Langmuir isotherm were elaborated by Changeux and Podleski.27 The sigmoid shape usually indicates that some type of cooperative action intervenes in the response to an activator. In the presence of a different activator, the sigmoid shape of the curve disappears and becomes a hyperbola with a nH of 1. This has been consistently observed with regulatory proteins: the cooperative interactions for the binding of a given ligand are modified by the presence of a different ligand.29 30 Such a conversion of shape is considered as an indication that the interaction between both classes of ligands are indirect or allosteric interactions. At saturating concentrations of activators, the maximal response to different activators differs according to the ionic environment. propagated by electric currents, the latter was postulated to be mediated by ACh released from the nerve ending and acting on the postsynaptic membrane.
Since the electrical parameters indicate many basic similarities between the properties of excitable membranes in axons and those at junctions, the assumption of two fundamentally different mechanisms of nerve impulse propagation was questioned (see, e.g., Erlanger3"). The theory of neurohumoral transmission was based on observations with classical methods of physiology and pharmacology. While these methods are essential for higher levels of integration, they are inadequate for the analysis of molecular events in a membrane of 100 A thickness. In view of the progress achieved in the understanding of chemical reactions in membranes in general and those in excitable membranes in particular, a re-evaluation of the theory of neurohumoral transmission appears appropriate.
One of the striking facts, particularly emphasized as being an indication of a mechanism of synaptic transmission different from that of conduction, is the powerful pharmacological action of ACh on junctions in contrast to its complete failure to affect axonal conduction. Similarly, more than a century ago, Claude Bernard observed that the activity of curare blocks only the transmission of the impulse from nerve to muscle, but does not affect nerve and muscle fibers. Curare has a higher affinity to the ACh-receptor than ACh. It is a receptor inhibitor and therefore prevents the depolarization by ACh released during activity and blocks the transmission across the junction. Claude Bernard applied curare to the frog sciatic nerve fiber, which is formed by several thousands of heavily myelinated axons and is surrounded by a sheath impervious to many chemical compounds. Dettbarn32 isolated a single axon from the frog sciatic nerve. On exposure to curare he found a rapid and reversible block of axonal conduction. A blocking action was also obtained when curare was applied to unmyelinated axons of the walking leg of lobster under appropriate experimental conditions. 33 ACh, curare, and related compounds that act as specific receptor activators or inhibitors are quaternary nitrogen derivatives and lipid-insoluble. The excitable membranes of axons are surrounded by structural barriers usually impervious to this type of compounds. Even in nonmyelinated axons the Schwann cell surrounding the excitable membrane usually prevents ACh from reaching the receptor in the membrane, although in some axons an action of ACh and its congeners on the electrical activity of axons may be obtained, for example, on those of the walking leg of lobster.34
Even if an unmyelinated axon does not react to ACh and its congeners, chemical treatment reducing the outside barriers may permit these compounds to reach the excitable membrane and to react with the receptor. In the squid giant axon, for example, the excitable membrane is surrounded by a Schwann cell about 4000 A thick. When these axons are exposed to ACh, curare, or neostigmine in highest concentrations, no effects are observed.35 In contrast, physostigmine, a tertiary nitrogen derivative and a potent inhibitor of AChesterase about equal in strength to neostigmine, blocks electrical activity. When the axoplasm of the exposed axons was extruded, physostigmine was found to have penetrated, while the other compounds had not entered the interior. However, in the last few years Rosenberg and his associates have demonstrated that the electrical activity of squid giant axons after their exposure to certain snake venoms is affected by ACh and curare in the way to be expected by their reaction with the receptor. 36 The venom itself, in the concentrations used and in the periods of time of exposure, had no effect oin electrical activity. Examination with electron microscopy revealed marked structural changes in the Schwann cell but none in the plasma membrane." Subsequent to the venom treatment radioactive ACh and curare were found to have penetrated into the interior. 38 The active component of the snake venom was found to be phospholipase A; its effect is fully accounted for by the formation of lysolecithin. 39 Frequently even synaptic junctions do not react to ACh or curare. The neuromuscular junctions of lobsters, for example, do not react to these compounds, although the concentration of ACh-esterase in these junctions is extremely high. On the other hand, lipid-soluble compounds such as physostigmine and DFP affect neuromuscular transmission of lobsters. Thus, the system there is functional, but protected by barriers against quaternary nitrogen derivatives. However, even when a junction reacts to ACh, the discrepancy between the amounts of ACh released in the membranes and the concentrations which have to be applied externally in order to be effective raises difficult questions. In the squid giant axon the order of magnitude of ACh released is 10-1O mole/cm2/impulse. This is very far from the pharmacologically active concentrations. Such a sensitive preparation as, for example, the electroplax fails to react to 10-5 M ACh unless physostigmine is added. This remarkable discrepancy raises the question as to the meaning of the amounts of ACh released by stimulation at the junction and found in the extracellular perfusion fluid. No trace of ACh appears in the perfusion fluids in the absence of physostigmine, even after prolonged stimulation. The same effect is observed with axons, in which the surrounding barrier is not entirely impervious to ACh: When the axons of the walking leg of lobster are kept in physostigmine, ACh appears in the outside fluid. Na+, K+, Ca++, and I\Lg++ ions have the same effects on the release of ACh in this preparation as those described for junctions.* The ACh-receptor, just like ACh-esterase, is localized in the excitable membranes of the nerve terminal and of the postsynaptic membrane: ACh, curare, neostignmine, and related compounds act on both membranes of the junctions; the nerve terminal seems to be even more sensitive than the postsynaptic membrane. 41 42 Since both proteins are present and functional in both membranes of the junction, it is reasonable to assume that the amplifier process takes place in the membranes of the junctions just as in those of the axon: ACh released in the membrane of the nerve terminal acts on the receptors there and triggers the sequence of reactions resulting in the influx of Na+ and the efflux of K+ ions. It is known that K+ ions release ACh from its storage form. Thus, when the K+ ions released from the terminal reach the postsynaptic membrane, they will release ACh there and trigger the same amplification process. By this amplification the signal will be much more efficient than it would be if it were directly released from one cell and would act on the specific protein in a second cell. Such an assumption is all the more difficult in view of the discrepancy of the order of 106-107 between the amounts of ACh released and those which are pharmacologically effective even in the presence of physostigmine. Chemical reactions in living cells are chemically and thermodynamically coupled and most of them are structurally organized. That the specific signal in one of the fastest cellular mechanisms known, i.e. nerve impulse propagation, is recognized by a specific protein in the membrane (where it is released and acts as a trigger of an amplifier there in a structurally organized way) thus seems more plausible than that there is a random process in which a chemical compound released in one cell must find the specific protein in another cell.
The specific chemical forces underlying cellular mechanisms, such as motility, vision, energy supply, etc., are remarkably similar throughout the animal kingdom. It has become apparent that this also applies to the specific chemical forces underlying bioelectricity, i.e. the specific proteins controlling the changes of ion permeability in excitable membranes. The great diversity of bioelectrical phenomena and the striking differences of pharmacological effects may be explained by the great variations of cellular structure and organization. The multiformity of shape, structure, and environment of synaptic junctions is bound to modify the effects of chemical reactions in the membranes or the action of compounds applied externally, as illustrated by some of the observations discussed. Structural differences markedly affect electrical parameters even in axons: Conduction velocity in different types of fibers varies from 0.1 to 100 meters per second. Knowledge of chemical composition and molecular organization of excitable membranes is much too limited for excluding differences between various types. The answer to these questions requires further analyses on the molecular level.
